Hasil Pencarian (1)
Amrubicin
DB06263
small molecule | CAS: 110267-81-7
Amrubicin is a third-generation synthetic anthracycline currently in development for the treatment of small cell lung cancer. Pharmion licensed the rights to Amrubicin in November 2006. In 2002, Amrubicin was approved and launched for sale in Japan based on P…
Kategori:
Anthracyclines and Related SubstancesAntineoplastic AgentsAntineoplastic and Immunomodulating Agents
+4
Target Protein:
DNA topoisomerase 2-alphaDNA
Waktu Paruh20-30 h [A32143]
…
Vol. DistribusiModerate volume of …
KlirensThe plasma pharmaco…
Genetik
-